Sign in to NCBI

Display Settings:

Format

Send to:

Choose Destination
Accession: PRJNA282664 ID: 282664

Homo sapiens (human)

Determination of ABO blood type for prostate cancer patients

See Genome Information for Homo sapiens
Navigate Up
This project is a component of the A Simple, Inexpensive Strategy for Predicting Potential Beneficial Clinical Responses on Prostate Cancer Vaccine Therapy
Navigate Across
1 additional project is a component of the A Simple, Inexpensive Strategy for Predicting Potential Beneficial Clinical Responses on Prostate Cancer Vaccine Therapy.
66643 additional projects are related by organism.
Purpose: This study uses a high-throughput glycan microarray to assign ABO blood type to patients from a clinical trial on PROSTVAC. More...
AccessionPRJNA282664; GEO: GSE68404
ScopeMultiisolate
OrganismHomo sapiens[Taxonomy ID: 9606]
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo; Homo sapiens
PublicationsMuthana SM et al., "ABO blood type correlates with survival on prostate cancer vaccine therapy.", Oncotarget, 2015 Oct 13;6(31):32244-56
SubmissionRegistration date: 29-Apr-2015
National Cancer Institute
RelevanceMedical
Project Data:
Resource NameNumber
of Links
Publications
PubMed1
PMC1
Other datasets
GEO DataSets1
GEO Data Details
ParameterValue
Data volume, Supplementary Mbytes9

Supplemental Content

Related information

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI
Support Center